Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003106280 | SCV003781599 | uncertain significance | not provided | 2024-11-11 | criteria provided, single submitter | clinical testing | This sequence change disrupts the translational stop signal of the CFI mRNA. It is expected to extend the length of the CFI protein by 24 additional amino acid residues. This variant is present in population databases (rs184356649, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with CFI-related conditions. ClinVar contains an entry for this variant (Variation ID: 2413947). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV005036647 | SCV005659931 | uncertain significance | Atypical hemolytic-uremic syndrome with I factor anomaly; Age related macular degeneration 13; Factor I deficiency | 2024-05-21 | criteria provided, single submitter | clinical testing |